© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
[1996] FCA 721
Federal Court of Australia
1996-08-15
Tamberlin J
Original judgment source is linked above.
CATCHWORDS TRADE PRACTICES - Trade Practices Act 1974 (Cth) ss 52, 53(aa), 53(c), 53(e), 53(g), 55A, 80, 80A - misleading conduct arising from assertions made in newspaper advertisements as to the efficiency, cost and comparative advantages of treatment proffered by particular impotence clinics - ambiguity - where an advertisement is capable of more than one meaning - question is whether a reasonable interpretation of it would lead a member of the class who was expected to read it into error - fair and reasonable reading - corrective advertising - purpose of corrective advertising to protect the public interest rather than to be punitive - importance of timing of corrective advertising - whether there is any current misapprehension resulting from misleading advertising - further appropriate remedies considered. Trade Practices Act 1974 (Cth) ss 52, 53(aa), 53(c), 53(e), 53(g), 55A, 80, 80A Grove Laboratories v Federal Trade Commissioner (1969) 418 F2d 489, cited Tobacco Institute of Australia Ltd v Australian Federation of Consumer Organisations (1992) 38 FCR 1, applied Makita (Australia) Pty Ltd v Black & Decker (Australasia) Pty Ltd (1990) 12 ATPR 40-030, cited Hospitals Contribution Fund of Australia Pty Ltd v Switzerland Australia Health Fund Pty Ltd (1988) 10 ATPR 40-846, cited Heydon, JD, Trade Practices Law, Butterworths AUSTRALIAN COMPETITION AND CONSUMER ASSOCIATION v ON CLINIC AUSTRALIA PTY LIMITED, MEN ONLY MEDICAL CLINIC PTY LIMITED, and POTENT-C CLINICS (AUSTRALIA) PTY LIMITED No NG 490 of 1996 Tamberlin J Sydney 15 August 1996
IN THE FEDERAL COURT OF AUSTRALIA) NEW SOUTH WALES DISTRICT REGISTRY) No. NG490 of 1996 GENERAL DIVISION ) BETWEEN: AUSTRALIAN COMPETITION AND CONSUMER COMMISSION Applicant AND: ON CLINIC AUSTRALIA PTY LIMITED Respondent MEN ONLY MEDICAL CLINIC PTY LIMITED Second Respondent POTENT-C CLINICS (AUSTRALIA) PTY LIMITED Third Respondent CORAM: TAMBERLIN J PLACE: SYDNEY DATED: 15 AUGUST 1996 REASONS FOR JUDGMENT TAMBERLIN J: On 18 June 1996 the applicant ("the Commission") commenced proceedings against the respondents under the Trade Practices Act 1974 (Cth) ("the Act"), under ss52, 53(aa), 53(c), 53(e), 53(g), 55A, 80 and 80A. The misleading conduct is said to arise from assertions made in newspaper advertisements as to the efficiency, cost, comparative advantages of treatment, and advice proffered by the respondents' clinics for men suffering from impotence.
As against the first respondent five misrepresentations are alleged. Specifically, the allegations are that the first respondent, trading as On Clinic and/or Professional Diagnostic Centres has caused advertisements to appear in the print media with the following misrepresentations: (a) (i) "The ONLY Impotence Treatment Ever Proven to Work!"; or (ii)"improve your SEX LIFE with the ONLY impotency treatment EVER proven to work"; (b) (i) "Bulk Billing. (No charge to you only medicare)"; or (ii)"All visits 100% Bulk Billed. Medicare (No cost to you)"; (c) (i) "4 treatment programmes with GUARANTEED RESULTS, in just 2 visits.."; or (ii)"... can be diagnosed and treated by medical doctors in only 2 consultations."; (d) (i) "4 treatment programmes with GUARANTEED RESULTS..."; or (ii)"PROVEN AND GUARANTEED to work"; and (e) "Diagnosis using unique medical equipment." As against the second and third respondents, the allegations are that they have placed advertisements in the print media with misrepresentations substantially similar to those set out in (b), (c)(ii) and (d)(ii) above. Nothing turns on the variations in wording. Each of the respondents is concerned in the treatment of impotence.
Background Evidence discloses that on 2 May 1996 Mr Lewis, an officer in the Commission's Enforcement Support Unit, had a meeting with Dr Pollak and Ms Wilson from a competitor of the respondent, operating under the name of the Men's Medical Clinic ("MMC"), regarding a complaint made on behalf of MMC in relation to the advertising by On Clinic. The initial complaint was directed to advertisements to the effect that the quadrojet treatment is the "only impotency treatment ever proven to work." On 7 May Dr Pollak wrote to the Commission alleging a further misrepresentation by On Clinic namely "Medicare Bulk Billing (no charge to patient)" when in fact customers had to pay for a course of the treatment as distinct from the consultations. On 7 May Mr Lewis wrote to the managing director of the first respondent, Mr Vaisman, referring to the complaint. He raised two matters. The first was the claim about the quadrojet pharmaceutical erection system and the assertion that it was "the only impotence treatment ever proven to work". The complaint was that in fact other treatments had been proven to work. The second matter raised was the claim concerning Medicare rebates namely that there is "100% Bulk Billing Medicare. No cost to you". Another similar advertisement was referred to which read, "Bulk Billing. No charge to you only Medicare". Mr Lewis pointed out that his understanding was that although the consultations were bulk billed in fact there were other treatment costs, including up to $390 for a course of injections, and that this course of treatment was not covered by Medicare. On 15 May the Commission sent a follow up letter. On 17 May, Mr Vaisman telephoned Mr Lewis and indicated that On Clinic wished to "fully co-operate" with the Commission and he undertook to change the advertisements in whatever manner the Commission considered necessary. Mr Vaisman proposed removal of the "ever" and "only" claim and said he would make it clear that "bulk billing" only applied to consultations. Mr Vaisman said that it was too late to cancel the advertisements for the forthcoming weekend but that they would be changed after that. Mr Lewis considered that these proposals were reasonable but that the Commission would need to see the revised advertisements. On the same day a faxed letter was sent to the applicant from the solicitor for On Clinic undertaking on behalf of On Clinic not to publish further advertisements with the offending language. Samples of the proposed new advertisements were enclosed and an indication was given that the client would submit for approval any modified advertisements proposed to be published in the future if required by the Commission. On 28 May 1996 a letter was sent by Dr McMahon, of the Australian Society of Impotence Medicine, making further complaints about the respondents' advertisements. On 4 June 1996 a further letter was written by the Commission to Mr Vaisman and the other respondents in relation to the assertions. This complaint was more detailed and related to claims referring to the "only proven treatment", "bulk billing", "only two consultations", "the guarantee" that the treatment would work and the reference to "unique diagnostic equipment". The substance of the assertions is set out earlier. The Commission required, by Friday 7 June 1996, undertakings that these assertions would cease and that there would be corrective advertising in a form acceptable to and approved by the Commission. On 7 June 1996 solicitors for the second and third respondents contacted Mr Lewis and informed him that their clients had just received the letter of 4 June and were working on a response. It was then agreed that it would be acceptable for the response to be provided by 11 June 1996. The Commission, not having received any satisfactory response to the letter of 4 June 1996, commenced these proceedings on 18 June 1996. Questions for Determination During the course of the proceedings the dispute narrowed substantially. In opening, counsel for the respondent adopted the position that of the five complaints against On Clinic alleged in the application, the first, which was to the effect that the only impotence treatment ever proven to work was that offered by the first respondent, was "exaggerated and unsatisfactory". I take this to be an acceptance, couched in felicitous language, that it was misleading. The words "only" and "ever" are quite unequivocal and admit no exceptions. On the admitted facts this assertion was clearly misleading. As to the other four representations, the position taken was that they were ambiguous and that if read one way they were true, but if read in another way, although they had "a core of truth", they had "a misleading aspect to them". Ambiguity Language which can reasonably suggest either a true proposition or a false one can come within the ambit of misleading conduct. It has been held, for example, that a statement that a product will relieve pain will be misleading if it relieves only one type of pain but not another: see Grove Laboratories v Federal Trade Commissioner (1969) 418 F2d 489. A number of other United States cases to similar effect are referred to in Heydon, Trade Practices Law, Volume 2, at para 11.710. See also the remarks of Hill J in Tobacco Institute of Australia Ltd v Australian Federation of Consumer Organisations (1992) 38 FCR 1 at 50, where his Honour said:
"Where, as in the present case, the advertisement is capable of more than one meaning, the question of whether the conduct of placing the advertisement in a newspaper is misleading or deceptive conduct, must be tested against each meaning which is reasonably open. This is perhaps but another way of saying that the advertisement will be misleading or likely to mislead or deceive if any reasonable interpretation of it would lead a member of the class, who can be expected to read it, into error: Keehn v Medical Benefits Fund of Australia Ltd (1977) 14 ALR 77 at 81 per Northrop J and cf the approach taken by Mason J in Parkdale." In relation to the representation concerning bulk billing, it was said that if the representation was read as relating to the cost of consultations only, then it was correct, but if it was read to include the cost of the course of treatment, in addition to consultations, then it was false. In my view, a reasonable and indeed the more likely construction of the words "without any charge to the patient" or "at no cost" would be that the total treatment is at no cost to the patient. There is no suggestion that the clinics' services are partly "at no cost". The words "no cost" like the word "free" have a certain allure and will almost always attract a strong favourable attention to a product or service. It is said the same observations apply in relation to the claims that impotence is capable of effective treatment in just four programs, with guaranteed results after only two visits; and the further claims that it could be successfully treated by medical doctors in only two consultations. The reference to "guaranteed" strongly connotes the certainty of a positive result and the assertion that successful treatment can be effected in "only" two consultations reinforces this message. While there is a large component of truth in these assertions, they are nevertheless capable of being read in such a way as to be misleading and deceptive. If it is sought to attract public attention and custom by the use of unqualified assertions of fact, then such assertions should be true as a matter of fact, if they are not to mislead and contravene the norms of conduct prescribed by the Act. Similarly, in relation to the representation in (d) (as set out earlier) to the effect that the results are guaranteed with respect to obtaining or sustaining an erection. The evidence indicates that in a high percentage of cases, the treatment is successful. Nevertheless, the reference to the treatment being "guaranteed" travels beyond the truth and is therefore false and likely to deceive or mislead. The final representation relates to the use by the first respondent of the expression "unique medical equipment". It is pointed out that if this is read to mean unique medical equipment in an unqualified sense, then it is false because the equipment known as the "duplex doppler" is to be found in most radiology practices or vascular diagnostic laboratories to which patients may be referred for testing. However, if it is construed to mean "unique" to impotency clinics, then it is said that the representation is true. The word "unique" on its ordinary meaning denotes exclusivity and, in my view, it is therefore likely to deceive or mislead if read in a fair and reasonable manner. Although, the statement appears in an advertisement concerning impotency clinics, nevertheless it asserts that these clinics have some equipment which is not otherwise available. There is no qualification nor is there anything in the language used to vary the literal meaning. It would have been a simple matter to qualify the advertisement but, no doubt, this would detract from its efficiency in attracting attention. Accordingly, the applicant has made out its case that each of the misrepresentations is misleading and deceptive on a fair and reasonable reading. Respondents' Position The respondent has adopted a pragmatic approach to this matter which is to be commended and is that there is little point in spending time analysing and resolving the complex scientific medical questions underlying the claims when considering the accuracy or otherwise of the statements where the claims can be amended to accord with the true position. This practical approach is appreciated by the Court. It does not mean that the statements are not misleading or deceptive but the conduct of the respondents in this respect is a matter which I have taken into account in considering the form of relief. At the outset of the proceedings counsel for the respondents indicated that they would not oppose the injunctions sought with the proviso that the injunction should only restrain them from the specific representations alleged and should not extend to the more general constraint sought in respect of any "promotional material which contains material which is false, misleading or deceptive or likely to mislead or deceive". I think this approach is appropriate and I will make orders restraining the representations referred to in the fourth, seventh and tenth paragraphs of the Statement of Claim as against the relevant respondents but not in the general form sought by the Commission in its Application. It was submitted that this is not an appropriate case in which to make declarations in relation to the representations but simply to grant injunctive relief. I do not accept this approach. Having found that the representations alleged are misleading or deceptive in the ways indicated above, I think it appropriate to make declarations to that effect. Leaving aside the question of injunctive relief the other issues raised relate to corrective advertising, the grant of compensation to persons affected by the misleading statements; allowing the applicant's officers access to the records to ensure that any compensation order is complied with, and developing and instituting a trade practices act corporate compliance program. Corrective Advertising The purpose of corrective advertising is to protect the public interest. See Makita (Australia) Pty Ltd v Black & Decker (Australasia) Pty Ltd (1990) 12 ATPR 41-030 at 51,477 to 51,478. Corrective advertising is intended to dispel incorrect or false impressions which may have been created as a result of deceptive or misleading conduct. It is not intended to be punitive. In any matter concerning corrective advertising the timing of such corrective advertising is of course important, as was pointed out by Morling J in Hospitals Contribution Fund Australia Pty Ltd v Switzerland Australia Health Fund Pty Ltd (1988) 10 ATPR 40-846 at 49,117. There is no principle that any particular period is appropriate as a point beyond which corrective adverting is not warranted. In the context of advertising it is necessary to examine the nature, extent and intensity of the advertising and the media in which it has been released with a view to deciding whether there could reasonably be any current misapprehension as a result of the advertisements. In the present case, I consider that some limited corrective advertising is warranted and in so doing I take the following matters into account:
Grove Laboratories
Federal Trade Commissioner
(1992) 38 FCR 1
(1977) 14 ALR 77